{"transactions":[{"id":1986106,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":116309,"kind":"person","name":"Kaufmann Hitto","position":1,"cik":"0001787104","reported_name":"Kaufmann Hitto","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-02-28T22:35:58.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":249080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on February 24, 2024 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":249080,"derivative":{"exercise_price":1.39,"expiration_date":"2033-02-24","underlying":"Common Stock","underlying_shares":249080},"source":{"system":"sec-edgar","filing":"0001437749-23-004958","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000143774923004958/rdgdoc.xml","form_type":"4"}},{"id":2374067,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":116309,"kind":"person","name":"Kaufmann Hitto","position":1,"cik":"0001787104","reported_name":"Kaufmann Hitto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-24T21:45:50.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":215819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on February 22, 2023 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":215819,"derivative":{"exercise_price":3.03,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":215819},"source":{"system":"sec-edgar","filing":"0001562180-22-001871","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218022001871/primarydocument.xml","form_type":"4"}},{"id":2802559,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":116309,"kind":"person","name":"Kaufmann Hitto","position":1,"cik":"0001787104","reported_name":"Kaufmann Hitto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-03-08T21:08:05.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on March 4, 2022 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":220000,"derivative":{"exercise_price":2.5,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001562180-21-002057","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218021002057/primarydocument.xml","form_type":"4"}},{"id":3237270,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":116309,"kind":"person","name":"Kaufmann Hitto","position":1,"cik":"0001787104","reported_name":"Kaufmann Hitto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-02T21:02:53.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on February 27, 2021 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":45000,"derivative":{"exercise_price":3.15,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-20-001865","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218020001865/primarydocument.xml","form_type":"4"}},{"id":3424664,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":116309,"kind":"person","name":"Kaufmann Hitto","position":1,"cik":"0001787104","reported_name":"Kaufmann Hitto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-03T21:49:05.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on August 30, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive calendar quarter thereafter beginning on December 31, 2020."}],"balance_after":300000,"derivative":{"exercise_price":4.65,"expiration_date":"2029-08-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001562180-19-004585","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218019004585/primarydocument.xml","form_type":"4"}}]}